Berair et al., 2013
| Publication | Publication Date | Title |
|---|---|---|
| Gauvreau et al. | Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma | |
| Gevaert et al. | Nasal IL-5 levels determine the response to anti–IL-5 treatment in patients with nasal polyps | |
| Zervas et al. | An algorithmic approach for the treatment of severe uncontrolled asthma | |
| Corren | New targeted therapies for uncontrolled asthma | |
| Pennino et al. | IL-22 suppresses IFN-γ–mediated lung inflammation in asthmatic patients | |
| Otani et al. | Anti–IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis | |
| Shikotra et al. | Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma | |
| Berair et al. | Asthma therapy and its effect on airway remodelling | |
| Geng et al. | Biologic therapies for allergic rhinitis and nasal polyposis | |
| Diver et al. | New and emerging drug treatments for severe asthma | |
| Gosens et al. | Bronchoconstriction and airway biology: potential impact and therapeutic opportunities | |
| Berair et al. | Rationale and clinical results of inhibiting interleukin-5 for the treatment of severe asthma | |
| US20220151581A1 (en) | Methods for treating idiopathic pulmonary fibrosis | |
| Hatchwell et al. | Salmeterol attenuates chemotactic responses in rhinovirus-induced exacerbation of allergic airways disease by modulating protein phosphatase 2A | |
| Jendzjowsky et al. | The role of airway myofibroblasts in asthma | |
| Zhang et al. | Inhibition of Rac1 activity alleviates PM2. 5-induced pulmonary inflammation via the AKT signaling pathway | |
| Hartley et al. | Severe asthma: novel advances in the pathogenesis and therapy | |
| Shrimanker et al. | Interleukin-5 inhibitors for severe asthma: rationale and future outlook | |
| Magnini et al. | Idiopathic pulmonary fibrosis: molecular endotypes of fibrosis stratifying existing and emerging therapies | |
| Walsh | Novel cytokine-directed therapies for asthma | |
| Giovannini-Chami et al. | New insights into the treatment of severe asthma in children | |
| van Dijk et al. | Developments in the management of severe asthma in children and adolescents: focus on dupilumab and tezepelumab | |
| US20230026808A1 (en) | Compounds, compositions, and methods for treating ischemia-reperfusion injury and/or lung injury | |
| Zhou et al. | Low temperature reduces occludin expression in bronchial epithelial cells: Implications in cold-induced asthma | |
| Walsh | Therapeutic potential of targeting interleukin 5 in asthma |